Fred Alger Management, LLC Halozyme Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $1.19 Million - $1.77 Million	29,801 New	29,801 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $375,367 - $485,415	10,050 New	10,050 $442,000
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $647,928 - $855,953	-16,682 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $2.12 Million - $2.76 Million	-53,690 Reduced 76.29%	16,682 $695,000
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $579,202 - $978,876	22,441 Added 46.82%	70,372 $3.01 Million
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $310,656 - $357,604	-12,069 Reduced 20.12%	47,931 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $32,500 - $53,620	2,000 Added 3.45%	60,000 $1.61 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $111,200 - $174,640	-8,000 Reduced 12.12%	58,000 $1.04 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $91,200 - $106,140	6,000 Added 10.0%	66,000 $1.02 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $2.58 Million - $3.02 Million	-175,121 Reduced 74.48%	60,000 $1.03 Million
Q1 2019 May 14, 2019	SELL	$13.94 - $17.58 $171,448 - $216,216	-12,299 Reduced 4.97%	235,121 $3.79 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $431,105 - $603,483	-32,341 Reduced 11.56%	247,420 $3.62 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $1.26 Million - $1.4 Million	-75,821 Reduced 21.32%	279,761 $5.08 Million
Q2 2018 Jul 19, 2018	SELL	$16.87 - $20.3 $847,498 - $1.02 Million	-50,237 Reduced 12.38%	355,582 $6 Million
Q1 2018 May 10, 2018	BUY	$17.06 - $21.2 $86,954 - $108,056	5,097 Added 1.27%	405,819 $7.95 Million
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $591,744 - $734,822	35,328 Added 9.67%	400,722 $8.12 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $4.3 Million - $6.36 Million	365,394	365,394 $6.35 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account